CSP7

CSP7 has been studied in 2 papers since 2023: none in people yet, 2 in animals. The research so far is in animals. The newest paper, Sep 13, 2024: “CSP7 Protects Alveolar Epithelial Cells by Targeting p53-Fibrinolytic Pathways During Lung Injuries”.

Intervention

2 papers study it7 findingsUpdated

PubChem

More peptides

  • 1 lab in 1 country
  • Funders: National Heart, Lung, and Blood Institute and 4 more
  • 4 of 7 findings with company ties
  • Animals2

What did studies of CSP7 find?

6

Studies of CSP7 measured 6 outcomes; the most studied are TP53 (1 study), telomere length (1) and AT2 cell viability (1).

TP53

downin mice1

1 study
  1. CSP7 decreases TP53 in mice.

    “induction of p53, PAI-1, SIAH1, and TRF1; as well as loss of TRF2 and TERT, which were reversed in wild-type mice after treatment with CSP7.”

    Animalsbleomycin- or chronic tobacco smoke-induced lung injurytype II alveolar epithelial cells

    CSP7 Protects Alveolar Epithelial Cells by Targeting p53-Fibrinolytic Pathways During Lung Injuries

    American journal of respiratory cell and molecular biology

More on TP53

Telomere length

upin mice1

1 study
  1. CSP7 increases telomere length in mice.

    “showed reduced telomere length; induction of p53, PAI-1, SIAH1, and TRF1; as well as loss of TRF2 and TERT, which were reversed in wild-type mice after treatment with CSP7.”

    Animalsbleomycin- or chronic tobacco smoke-induced lung injurytype II alveolar epithelial cells

    CSP7 Protects Alveolar Epithelial Cells by Targeting p53-Fibrinolytic Pathways During Lung Injuries

    American journal of respiratory cell and molecular biology

More on Telomere length

AT2 cell viability

upin cells1

1 study
  1. CSP7 improves AT2 cell viability in cells.

    “treatment of AECs, AT2 cells, or lung tissue slices from patients with COPD or mice with CS-LI with a seven amino acid caveolin-1 scaffolding domain peptide (CSP7) reduced mucus hypersecretion in AECs and improved AT2 cell viability”

    CellsCS-induced lung injury or COPD

    Caveolin-1-derived peptide attenuates cigarette smoke-induced airway and alveolar epithelial injury

    American journal of physiology. Lung cellular and molecular physiology

Mucus hypersecretion

downin cells1

1 study
  1. CSP7 decreases mucus hypersecretion in cells.

    “treatment of AECs, AT2 cells, or lung tissue slices from patients with COPD or mice with CS-LI with a seven amino acid caveolin-1 scaffolding domain peptide (CSP7) reduced mucus hypersecretion in AECs”

    CellsCS-induced lung injury or COPD

    Caveolin-1-derived peptide attenuates cigarette smoke-induced airway and alveolar epithelial injury

    American journal of physiology. Lung cellular and molecular physiology

Lung function

upin mice1

1 study
  1. CSP7 improves lung function in mice.

    “treatment of wild-type mice having CS-LI with CSP7 by intraperitoneal injection or nebulization via airways attenuated mucus hypersecretion, alveolar injury, and significantly improved lung function”

    AnimalsCS-induced lung injury

    Caveolin-1-derived peptide attenuates cigarette smoke-induced airway and alveolar epithelial injury

    American journal of physiology. Lung cellular and molecular physiology

Alveolar injury

downin mice1

1 study
  1. CSP7 decreases alveolar injury in mice.

    “treatment of wild-type mice having CS-LI with CSP7 by intraperitoneal injection or nebulization via airways attenuated mucus hypersecretion, alveolar injury, and significantly improved lung function”

    AnimalsCS-induced lung injury

    Caveolin-1-derived peptide attenuates cigarette smoke-induced airway and alveolar epithelial injury

    American journal of physiology. Lung cellular and molecular physiology

What acts on CSP7?

1

Studies name 1 thing that act on CSP7, most often PLAU (1 study).

PLAU

is required forin mice1

1 study
  1. PLAU is required for CSP7 in mice.

    “whereas uPA-/- mice failed to respond to CSP7 treatment”

    Animalsshown by uPA-/- failing to respond to CSP7type II alveolar epithelial cells

    CSP7 Protects Alveolar Epithelial Cells by Targeting p53-Fibrinolytic Pathways During Lung Injuries

    American journal of respiratory cell and molecular biology

More on PLAU

Latest